HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Medical treatment of lymphedema with benzopyrones. Experimental basis and applications].

Abstract
The frequency of secondary lymphedema occurrence following breast cancer therapy has been decreasing since new conservative surgical treatment and radiotherapy are applied. However, about 20% of female patients treated for breast cancer will develop mild swelling of the arm or forearm and seek specific treatment. Decongestive physiotherapy remains the most effective treatment, although medical treatment is often necessary. Coumarin, tested both in vitro and in vivo, has yielded true stimulation of lymphatic function. Like other benzopyrone derivatives, coumarin acts through macrophage stimulation. A randomized double blind study versus placebo has confirmed the occurrence of significant improvement of these mild swelling cases, and recommend the use of coumarin as supplemental therapy in mild lymphedema.
AuthorsA Pecking
JournalJournal des maladies vasculaires (J Mal Vasc) Vol. 15 Issue 2 Pg. 157-8 ( 1990) ISSN: 0398-0499 [Print] FRANCE
Vernacular TitleTraitement médical du lymphoedème par les benzopyrones. Bases expérimentales et applications.
PMID2358758 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Coumarins
Topics
  • Arm
  • Coumarins (therapeutic use)
  • Female
  • Humans
  • Lymphedema (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: